Xtant Medical to earn $15M in stock sale

Xtant Medical Holdings, a medical device company focused on surgical solutions for the spine, has agreed to sell 20 million shares of common stock to an investor, resulting in gross proceeds of $15 million, according to a July 3 report from Market Screener. 

Advertisement

Xtant plans to use the proceeds for working capital and other general corporate purposes, according to the report. The sales closed July 6. 

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Advertisement

Next Up in Spine

Advertisement

Comments are closed.